Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inventeur is a private medical technology company focused on anesthesiology and procedural sedation, with a particular emphasis on non-operating room anesthesia settings. Its lead and apparently sole disclosed product is AIM, an FDA-cleared Class II intraoral device that combines a bite block, direct pharyngeal oxygen delivery, and carbon dioxide sampling for capnography monitoring during minimally or moderately sedated procedures. The company positions AIM as a lower-cost, simpler alternative to high-flow nasal cannula systems while preserving oral access for endoscopy and airway rescue. Inventeur has described itself as a holding company of medical technologies in anesthesiology, but public evidence currently points primarily to the AIM device franchise. The company appears to be active, privately held, and based in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inventeur.